Diabetes Drug May Be Linked With An Increased Rate of Death

A review by the U.S. Food and Drug Administration (FDA) has found that the AstraZeneca Plc’s diabetes drug, Onglyza, may be associated with an increased rate of death. A trial was underway of more than 16,000 patients taking Onglyza. It has been reported that these...